Tsumura & Co.
Tsumura & Co. (TSMRF) Financial Performance & Income Statement Overview
Review Tsumura & Co. (TSMRF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Tsumura & Co. (TSMRF) Income Statement & Financial Overview
Analyze Tsumura & Co.’s TSMRF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $44.32B | $47.70B | $45.38B | $43.69B |
| Cost of Revenue | $23.54B | $23.77B | $22.34B | $20.86B |
| Gross Profit | $20.78B | $23.93B | $23.04B | $22.83B |
| Gross Profit Ratio | $0.47 | $0.50 | $0.51 | $0.52 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $13.03B | $12.63B | $12.54B | $12.26B |
| Operating Expenses | $13.03B | $12.63B | $12.54B | $12.26B |
| Total Costs & Expenses | $36.58B | $36.40B | $34.88B | $33.12B |
| Interest Income | $183.00M | $150.00M | $137.00M | $158.00M |
| Interest Expense | $143.00M | $125.00M | $138.00M | $112.00M |
| Depreciation & Amortization | $2.83B | $2.74B | $2.80B | $2.81B |
| EBITDA | $9.97B | $14.04B | $13.30B | $13.38B |
| EBITDA Ratio | $0.23 | $0.29 | $0.29 | $0.31 |
| Operating Income | $7.75B | $11.30B | $10.50B | $10.57B |
| Operating Income Ratio | $0.17 | $0.24 | $0.23 | $0.24 |
| Other Income/Expenses (Net) | -$182.00M | $1.53B | -$1.16B | $5.24B |
| Income Before Tax | $7.56B | $12.83B | $9.35B | $15.82B |
| Income Before Tax Ratio | $0.17 | $0.27 | $0.21 | $0.36 |
| Income Tax Expense | $1.24B | $3.36B | $2.005B | $4.42B |
| Net Income | $5.86B | $9.06B | $6.32B | $11.18B |
| Net Income Ratio | $0.13 | $0.19 | $0.14 | $0.26 |
| EPS | $77.24 | $119.37 | $83.26 | $147.24 |
| Diluted EPS | $77.24 | $119.37 | $83.26 | $147.24 |
| Weighted Avg Shares Outstanding | $75.88M | $75.94M | $75.93M | $75.93M |
| Weighted Avg Shares Outstanding (Diluted) | $75.88M | $75.94M | $75.93M | $75.93M |
The company's financials show resilient growth, with revenue advancing from $43.69B in Q1 2024 to $44.32B in Q4 2024. Gross profit remained healthy with margins at 47% in Q4 2024 compared to 52% in Q1 2024. Operating income hit $7.75B last quarter, sustaining a consistent 17% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $9.97B. Net income dropped to $5.86B, while earnings per share reached $77.24. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan